Evidence map›Paper›PMID 34755133›Full record

ArticleCell reports. Medicine2021

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis.

Selena Ferrian, Candace C Liu, Erin F McCaffrey, Rashmi Kumar, Theodore S Nowicki, David W Dawson, Alex Baranski, John A Glaspy, Antoni Ribas, Sean C Bendall and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cell reports. Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Neuroimmunophysiology of the gastrointestinal tract.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nivolumab-induced tumour-like gastritis: A case report.World journal of clinical cases · 2023
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Selena FerrianDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Candace C LiuDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Erin F McCaffreyDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Rashmi KumarDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Theodore S NowickiDepartment of Pediatrics, Division of Pediatric Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
David W DawsonJonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Alex BaranskiDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
John A GlaspyDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA 90095, USA.
Antoni RibasEli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Sean C BendallDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Michael AngeloDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Stanford University · USUniversity of California, Los Angeles · USParker Institute for Cancer Immunotherapy · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)U24CA224309 · NCI · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Holden T. Maecker · 2017 to 2026
$19.9M
Tracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2013 to 2025
$17.3M
Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2015 to 2025
$13.5M
Project 3: Modeling and overcoming resistance to melanoma immunotherapyP01CA244118 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LO, ROGER S · 2020 to 2024
$12.8M
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers DiseaseR01AG057915 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$4.5M
Deciphering the Glycan Code in Human Alzheimer’s Disease BrainR01AG078702 · NIA · UNIVERSITY OF KENTUCKY · PI Peggi M Angel, Sean Curtis Bendall · 2022 to 2026
$3.8M
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam ImagingR01AG056287 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$2.6M
Predictive signatures in breast cancer using multiplexed ion beam imagingDP5OD019822 · OD · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL · 2014 to 2018
$2.0M
Functional epigenomics of transgenic cellular immunotherapies for cancerK08CA241088 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NOWICKI, THEODORE SCOTT · 2021 to 2025
$909k
A single-cell platform to discover and study regulators of human developmentR00GM104148 · NIGMS · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2014 to 2016
$747k
NCI NIH HHS K08 CA241088NCI NIH HHS P01 CA244118NCI NIH HHS U24 CA224309NIAID NIH HHS T32 AI007290NIAID NIH HHS U19 AI104209NIAID NIH HHS U19 AI116484NIA NIH HHS R01 AG056287NIA NIH HHS R01 AG057915NIA NIH HHS R01 AG078702NIGMS NIH HHS R00 GM104148NIH HHS DP5 OD019822
6 · The paper itself

Abstract

Immune checkpoint blockade using PD-1 inhibition is an effective approach for treating a wide variety of cancer subtypes. While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported. Here, we present a case of nivolumab-associated autoimmune gastritis. To elucidate the immunology underlying this condition, we leverage multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to identify the presence and proportion of infiltrating immune cells from a single section of biopsy specimen. Using MIBI-TOF, we analyze formalin-fixed, paraffin-embedded human gastric tissue with 28 labels simultaneously. Our analyses reveal a gastritis characterized by severe mucosal injury, interferon gamma (IFN-γ)-producing gastric epithelial cells, and mixed inflammation that includes CD8 and CD4 T cell infiltrates with reduced expression of granzyme B and FOXP3, respectively. Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN-γ-producing epithelial cells as possible contributors to the nivolumab-associated gastritis.

Indexed as

Antineoplastic Agents, ImmunologicalBiopsyCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesColonic NeoplasmsEpithelial CellsFemaleForkhead Transcription FactorsGastric MucosaGastritisGene ExpressionGranzymesHumansImmune Checkpoint InhibitorsInterferon-gammaMiddle AgedAntineoplastic Agents, ImmunologicalForkhead Transcription FactorsFOXP3 protein, humanGranzymesImmune Checkpoint InhibitorsInterferon-gammaNivolumabgastritisIFN-γinterferon gammaMIBI-TOFnivolumabprogrammed death 1

Identifiers

PMID34755133
PMCPMC8561237
OpenAlexW3205860754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.